The liver kinase B1 (LKB1)-dependent activation of AMPK and reduction of mammalian target of rapamycin (mTOR) activity may be significant contributors to the inhibitory effects of metformin on cancer cell growth and proliferation ( 151 ).
← all excerpts
Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges.
1
—
—